Population | Population ‘All’ | Population 1 | Population 2 | Other coughs | Cough-variant asthma | Atopic/allergic cough | |
---|---|---|---|---|---|---|---|
Number of patients | N = 6,038 | N = 3,500 | N = 2,538 | N = 1,444 | N = 1,026 | N = 105 | |
Age at index date | |||||||
Mean ± SD | 43.7 ± 12.2 | 42.3 ± 12.2 | 45.6 ± 11.9 | 45.3 ± 11.9 | 45.8 ± 11.8 | 46.2 ± 11.8 | |
≥ 60 years | 564 (9.3%) | 283 (8.1%) | 281 (11.1%) | 153 (10.6%) | 124 (12.1%) | 10 (9.5%) | |
Gender | |||||||
Men | 2,308 (38.2%) | 1,402 (40.1%) | 906 (35.7%) | 503 (34.8%) | 369 (36.0%) | 42 (40.0%) | |
Women | 3,730 (61.8%) | 2,098 (59.9%) | 1,632 (64.3%) | 941 (65.2%) | 657 (64.0%) | 63 (60.0%) | |
Medical facility size | N = 6,000 | N = 3,483 | N = 2,517 | N = 1,444 | N = 1,017 | N = 105 | |
1–19 beds | 4,196 (69.9%) | 2,197 (63.1%) | 1,999 (79.4%) | 1,202 (83.9%) | 783 (77.0%) | 65 (61.9%) | |
20–199 beds | 521 (8.7%) | 373 (10.7%) | 148 (5.9%) | 46 (3.2%) | 85 (8.4%) | 10 (9.5%) | |
≥ 200 beds | 1,283 (21.4%) | 913 (26.2%) | 370 (14.7%) | 184 (12.8%) | 149 (14.7%) | 30 (28.6%) | |
Cough-related diseases | |||||||
ARNI | 3,132 (51.9%) | 1,688 (48.2%) | 1,444 (56.9%) | 776 (53,7%) | 619 (60.3%) | 71 (67,6%) | |
Asthma | 2,517 (41.7%) | 1,620 (46.3%) | 897 (35.3%) | 506 (35,0%) | 340 (33.1%) | 54 (51,4%) | |
GERD | 829 (13.7%) | 448 (12.8%) | 381 (15.0%) | 185 (12,8%) | 179 (17.5%) | 20 (19,0%) | |
Paranasal sinusitis | 724 (12.0%) | 455 (13.0%) | 269 (10.6%) | 170 (11,8%) | 89 (8.7%) | 8 (7,6%) | |
CAID | 482 (8.0%) | 312 (8.9%) | 170 (6.7%) | 91 (6,3%) | 68 (6.6%) | 10 (9,5%) | |
Chronic rhinitis | 155 (2.6%) | 79 (2.3%) | 76 (3.0%) | 59 (4,1%) | 19 (1.9%) | 0 | |
Postnasal drip | 50 (0.8%) | 22 (0.6%) | 28 (1.1%) | 3 (0,2%) | 25 (2.4%) | 1 (1,0%) | |
Vocal cord dysfunction | 74 (1.2%) | 46 (1.3%) | 28 (1.1%) | 15 (1,0%) | 13 (1.3%) | 0 | |
Emphysema | 48 (0.8%) | 39 (1.1%) | 9 (0.4%) | 5 (0,3%) | 3 (0.3%) | 1 (1,0%) | |
Nasal polyps | 6 (0.1%) | 4 (0.1%) | 2 (0.1%) | 2 (0,1%) | 0 | 0 |